Regulatory T cells—the renaissance of the suppressor T cells

References

• Miller J. F. Immunological function of the thymus. Lancet 1961; 2: 748–9
   PubMed Web of Science ®Google Scholar
• Miller J. F., Mitchell G. F. Cell to cell interaction in the immune response. I. Hemolysin‐forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med 1968; 128: 801–20
   PubMed Web of Science ®Google Scholar
• Gershon R. K., Cohen P., Hencin R., Liebhaber S. A. Suppressor T cells. J Immunol 1972; 108: 586–90
   PubMed Web of Science ®Google Scholar
• Gershon R. K., Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970; 18: 723–37
   PubMed Web of Science ®Google Scholar
• Gershon R. K. A disquisition on suppressor T cells. Transplant Rev 1975; 26: 170–85
   PubMed Web of Science ®Google Scholar
• Okumura K., Takemori T., Tokuhisa T., Tada T. Specific enrichment of the suppressor T cell bearing I‐J determinants: parallel functional and serological characterizations. J Exp Med 1977; 146: 1234–45
   Google Scholar
• Tada T., Taniguchi M., David C. S. Properties of the antigen‐specific suppressive T‐cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T‐cell factor in the H‐2 histocompatibility complex. J Exp Med 1976; 144: 713–25
   Google Scholar
• Kronenberg M., Steinmetz M., Kobori J., Kraig E., Kapp J. A., Pierce C. W., et al. RNA transcripts for I‐J polypeptides are apparently not encoded between the I‐A and I‐E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A 1983; 80: 5704–8
   Google Scholar
• Steinmetz M., Minard K., Horvath S., McNicholas J., Srelinger J., Wake C., et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 1982; 300: 35–42
   PubMedGoogle Scholar
• Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self‐tolerance maintained by activated T cells expressing IL‐2 receptor alpha‐chains (CD25). Breakdown of a single mechanism of self‐tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151–64
   PubMed Web of Science ®Google Scholar
• Thornton A. M., Shevach E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287–96
   PubMed Web of Science ®Google Scholar
• Khattri R., Cox T., Yasayko S. A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337–42
   PubMed Web of Science ®Google Scholar
• Schubert L. A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S. F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001; 276: 37672–9
   PubMed Web of Science ®Google Scholar
• Chatila T. A., Blaeser F., Ho N., Lederman H. M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head‐related protein, is mutated in X‐linked autoimmunity‐allergic disregulation syndrome. J Clin Invest 2000; 106: R75–81
   PubMed Web of Science ®Google Scholar
• Brunkow M. E., Jeffery E. W., Hjerrild K. A., Paeper B., Clark L. B., Yasayko S. A., et al. Disruption of a new forkhead/winged‐helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27: 68–73
   PubMed Web of Science ®Google Scholar
• Wildin R. S., Ramsdell F., Peake J., Faravelli F., Casanova J. L., Buist N., et al. X‐linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18–20
   PubMed Web of Science ®Google Scholar
• Bennett C. L., Christie J., Ramsdell F., Brunkow M. E., Ferguson P. J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X‐linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20–1
   PubMed Web of Science ®Google Scholar
• Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057–61
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A., Rudensky A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330–6
   PubMed Web of Science ®Google Scholar
• Walker M. R., Kasprowicz D. J., Gersuk V. H., Benard A., Van Landeghen M., Buckner J. H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J Clin Invest 2003; 112: 1437–43
   PubMed Web of Science ®Google Scholar
• Morgan M. E., van Bilsen J. H., Bakker A. M., Heemskerk B., Schilham M. W., Hartgers F. C., et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005; 66: 13–20
   PubMed Web of Science ®Google Scholar
• Allan S. E., Crome S. Q., Crellin N. K., Passerini L., Steiner T. S., Bacchetta R., et al. Activation‐induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345–54
   PubMed Web of Science ®Google Scholar
• Wang J., Ioan‐Facsinay A., van der Voort E. I., Huizinga T. W., Toes R. E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007; 37: 129–38
   PubMed Web of Science ®Google Scholar
• Roncador G., Brown P. J., Maestre L., Hue S., Martinez‐Torrecuadrada J. L., Ling K. L., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level. Eur J Immunol 2005; 35: 1681–91
   PubMed Web of Science ®Google Scholar
• Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 1643–56
   PubMed Web of Science ®Google Scholar
• Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self‐peptide. Nat Immunol 2001; 2: 301–6
   PubMed Web of Science ®Google Scholar
• Chatenoud L., Bach J. F. Adaptive human regulatory T cells: myth or reality?. J Clin Invest 2006; 116: 2325–7
   PubMed Web of Science ®Google Scholar
• Roncarolo M. G., Bacchetta R., Bordignon C., Narula S., Levings M. K. Type 1 T regulatory cells. Immunol Rev 2001; 182: 68–79
   PubMed Web of Science ®Google Scholar
• Adorini L., Giarratana N., Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 2004; 16: 127–34
   PubMed Web of Science ®Google Scholar
• Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237–40
   PubMed Web of Science ®Google Scholar
• Chen W., Jin W., Hardegen N., Lei K. J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25‐ naive T cells to CD4+CD25+ regulatory T cells by TGF‐beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875–86
   PubMed Web of Science ®Google Scholar
• Fantini M. C., Becker C., Monteleone G., Pallone F., Galle P. R., Neurath M. F. Cutting edge: TGF‐beta induces a regulatory phenotype in CD4+CD25‐ T cells through Foxp3 induction and down‐regulation of Smad7. J Immunol 2004; 172: 5149–53
   PubMed Web of Science ®Google Scholar
• Delgado M., Chorny A., Gonzalez‐Rey E., Ganea D. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J Leukoc Biol 2005; 78: 1327–38
   PubMed Web of Science ®Google Scholar
• Fernandez‐Martin A., Gonzalez‐Rey E., Chorny A., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol 2006; 36: 318–26
   PubMed Web of Science ®Google Scholar
• Baratelli F., Lin Y., Zhu L., Yang S. C., Heuze‐Vourc'h N., Zeng G., et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005; 175: 1483–90
   PubMed Web of Science ®Google Scholar
• Jonuleit H., Schmitt E., Steinbrink K., Enk A. H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001; 22: 394–400
   PubMed Web of Science ®Google Scholar
• Shevach E. M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389–400
   PubMed Web of Science ®Google Scholar
• Thornton A. M., Shevach E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183–90
   PubMed Web of Science ®Google Scholar
• Tang Q., Adams J. Y., Tooley A. J., Bi M., Fife B. T., Serra P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7: 83–92
   PubMed Web of Science ®Google Scholar
• Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A. H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002; 196: 255–60
   PubMed Web of Science ®Google Scholar
• Stassen M., Fondel S., Bopp T., Richter C., Muller C., Kubach J., et al. Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004; 34: 1303–11
   PubMed Web of Science ®Google Scholar
• Nishizuka Y., Sakakura T. Thymus and reproduction: sex‐linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969; 166: 753–5
   PubMed Web of Science ®Google Scholar
• Powrie F. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann N Y Acad Sci 2004; 1029: 132–41
   Google Scholar
• Annacker O., Asseman C., Read S., Powrie F. Interleukin‐10 in the regulation of T cell‐induced colitis. J Autoimmun 2003; 20: 277–9
   PubMed Web of Science ®Google Scholar
• Uhlig H. H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., et al. Characterization of Foxp3+CD4+CD25+ and IL‐10‐Secreting CD4+CD25+ T Cells during Cure of Colitis. J Immunol 2006; 177: 5852–60
   PubMedGoogle Scholar
• Kullberg M. C., Hay V., Cheever A. W., Mamura M., Sher A., Letterio J. J., et al. TGF‐beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005; 35: 2886–95
   PubMed Web of Science ®Google Scholar
• Maloy K. J., Salaun L., Cahill R., Dougan G., Saunders N. J., Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine‐dependent mechanisms. J Exp Med 2003; 197: 111–9
   PubMed Web of Science ®Google Scholar
• Fahlen L., Read S., Gorelik L., Hurst S. D., Coffman R. L., Flavell R. A., et al. T cells that cannot respond to TGF‐beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 2005; 201: 737–46
   PubMed Web of Science ®Google Scholar
• Fantini M. C., Becker C., Tubbe I., Nikolaev A., Lehr H. A., Galle P., et al. Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006; 55: 671–80
   PubMed Web of Science ®Google Scholar
• Makita S., Kanai T., Oshima S., Uraushihara K., Totsuka T., Sawada T., et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004; 173: 3119–30
   PubMed Web of Science ®Google Scholar
• Kelsen J., Agnholt J., Hoffmann H. J., Romer J. L., Hvas C. L., Dahlerup J. F. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin Exp Immunol 2005; 141: 549–57
   PubMed Web of Science ®Google Scholar
• Zamvil S. S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990; 8: 579–621
   PubMed Web of Science ®Google Scholar
• Zhang X., Koldzic D. N., Izikson L., Reddy J., Nazareno R. F., Sakaguchi S., et al. IL‐10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 249–56
   PubMed Web of Science ®Google Scholar
• Tisch R., McDevitt H. Insulin‐dependent diabetes mellitus. Cell. 1996; 85: 291–7
   Google Scholar
• Delovitch T. L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997; 7: 727–38
   PubMed Web of Science ®Google Scholar
• King C., Sarvetnick N. Organ‐specific autoimmunity. Curr Opin Immunol 1997; 9: 863–71
   PubMed Web of Science ®Google Scholar
• Poulin M., Haskins K. Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J Immunol 2000; 164: 3072–8
   Google Scholar
• Salomon B., Lenschow D. J., Rhee L., Ashourian N., Singh B., Sharpe A., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431–40
   PubMed Web of Science ®Google Scholar
• Salomon B., Rhee L., Bour‐Jordan H., Hsin H., Montag A., Soliven B., et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7‐2‐deficient NOD mice. J Exp Med 2001; 194: 677–84
   PubMedGoogle Scholar
• Masteller E. L., Warner M. R., Tang Q., Tarbell K. V., McDevitt H., Bluestone J. A. Expansion of functional endogenous antigen‐specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053–9
   PubMed Web of Science ®Google Scholar
• Tarbell K. V., Yamazaki S., Olson K., Toy P., Steinman R. M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467–77
   PubMed Web of Science ®Google Scholar
• Every A. L., Kramer D. R., Mannering S. I., Lew A. M., Harrison L. C. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J Immunol 2006; 176: 4608–15
   PubMed Web of Science ®Google Scholar
• Bresson D., Togher L., Rodrigo E., Chen Y., Bluestone J. A., Herold K. C., et al. Anti‐CD3 and nasal proinsulin combination therapy enhances remission from recent‐onset autoimmune diabetes by inducing Tregs. J Clin Invest 2006; 116: 1371–81
   PubMed Web of Science ®Google Scholar
• Snell G. D., Higgins G. F. Alleles at the histocompatibility‐2 locus in the mouse as determined by tumor transplantation. Genetics 1951; 36: 306–10
   PubMed Web of Science ®Google Scholar
• Snell G. D. The genetics of transplantation. J Natl Cancer Inst. 1953; 14: 691–700
   Google Scholar
• Billingham R. E., Brent L., Medawar P. B. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603–6
   PubMed Web of Science ®Google Scholar
• Owen R. D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102: 400–01
   PubMed Web of Science ®Google Scholar
• Lance E. M., Medawar P. B. Survival of skin heterografts under treatment with antilymphocytic serum. Lancet 1968; 1: 1174–6
   Google Scholar
• Gershon R. K., Kondo K. Infectious immunological tolerance. Immunology 1971; 21: 903–14
   PubMed Web of Science ®Google Scholar
• Hall B. M., Jelbart M. E., Gurley K. E., Dorsch S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162: 1683–94
   Google Scholar
• Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., et al. “Infectious” transplantation tolerance. Science 1993; 259: 974–7
   PubMed Web of Science ®Google Scholar
• Waldmann H., Cobbold S. Regulating the immune response to transplants. A role for CD4+ regulatory cells?. Immunity 2001; 14: 399–406
   PubMed Web of Science ®Google Scholar
• Yin D., Fathman C. G. CD4‐positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 6339–45
   PubMed Web of Science ®Google Scholar
• Davies J. D., Martin G., Phillips J., Marshall S. E., Cobbold S. P., Waldmann H. T cell regulation in adult transplantation tolerance. J Immunol 1996; 157: 529–33
   Google Scholar
• Honey K., Cobbold S. P., Waldmann H. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 1999; 163: 4805–10
   PubMedGoogle Scholar
• Arima T., Lehmann M., Flye M. W. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX‐38) anti‐CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation 1997; 63: 284–92
   PubMed Web of Science ®Google Scholar
• Zhai Y., Shen X. D., Lehmann M., Busuttil R., Volk H. D., Kupiec‐Weglinski J. W. T cell subsets and in vitro immune regulation in “infectious” transplantation tolerance. J Immunol 2001; 167: 4814–20
   PubMed Web of Science ®Google Scholar
• Graca L., Cobbold S. P., Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641–6
   PubMed Web of Science ®Google Scholar
• Taylor P. A., Lees C. J., Blazar B. R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft‐versus‐host disease lethality. Blood 2002; 99: 3493–9
   PubMed Web of Science ®Google Scholar
• Godfrey W. R., Spoden D. J., Ge Y. G., Baker S. R., Liu B., Levine B. L., et al. Cord blood CD4(+)CD25(+)‐derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750–8
   PubMed Web of Science ®Google Scholar
• Tafuri A., Alferink J., Moller P., Hammerling G. J., Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270: 630–3
   PubMed Web of Science ®Google Scholar
• Woodruff M. F. Transplantation immunity and the immunological problem of pregnancy. Proc R Soc Lond B Biol Sci 1958; 148: 68–75
   Google Scholar
• Zenclussen A. C., Gerlof K., Zenclussen M. L., Sollwedel A., Bertoja A. Z., Ritter T., et al. Abnormal T‐cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy‐induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005; 166: 811–22
   PubMed Web of Science ®Google Scholar
• Saito S., Sasaki Y., Sakai M. CD4(+)CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65: 111–20
   PubMed Web of Science ®Google Scholar
• Sasaki Y., Sakai M., Miyazaki S., Higuma S., Shiozaki A., Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10: 347–53
   PubMed Web of Science ®Google Scholar
• Heikkinen J., Mottonen M., Alanen A., Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004; 136: 373–8
   PubMed Web of Science ®Google Scholar
• Somerset D. A., Zheng Y., Kilby M. D., Sansom D. M., Drayson M. T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset. Immunology 2004; 112: 38–43
   PubMed Web of Science ®Google Scholar
• Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., Nakayama E. Tumor rejection by in vivo administration of anti‐CD25 (interleukin‐2 receptor alpha) monoclonal antibody. Cancer Res 1999; 59: 3128–33
   PubMed Web of Science ®Google Scholar
• Sutmuller R. P., van Duivenvoorde L. M., van Elsas A., Schumacher T. N., Wildenberg M. E., Allison J. P., et al. Synergism of cytotoxic T lymphocyte‐associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823–32
   PubMed Web of Science ®Google Scholar
• Peng L., Kjaergaard J., Plautz G. E., Awad M., Drazba J. A., Shu S., et al. Tumor‐induced L‐selectinhigh suppressor T cells mediate potent effector T cell blockade and cause failure of otherwise curative adoptive immunotherapy. J Immunol 2002; 169: 4811–21
   PubMedGoogle Scholar
• Gerlini G., Tun‐Kyi A., Dudli C., Burg G., Pimpinelli N., Nestle F. O. Metastatic melanoma secreted IL‐10 down‐regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004; 165: 1853–63
   PubMed Web of Science ®Google Scholar
• Van Belle P., Rodeck U., Nuamah I., Halpern A. C., Elder D. E. Melanoma‐associated expression of transforming growth factor‐beta isoforms. Am J Pathol 1996; 148: 1887–94
   PubMed Web of Science ®Google Scholar
• Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942–9
   PubMed Web of Science ®Google Scholar
• Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., et al. Treatment of advanced tumors with agonistic anti‐GITR mAb and its effects on tumor‐infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med 2005; 202: 885–91
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F., Larmonier N., Schmitt E., Parcellier A., Cathelin D., Garrido C., et al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 2004; 34: 336–44
   PubMed Web of Science ®Google Scholar
• Ercolini A. M., Ladle B. H., Manning E. A., Pfannenstiel L. W., Armstrong T. D., Machiels J. P., et al. Recruitment of latent pools of high‐avidity CD8(+) T cells to the antitumor immune response. J Exp Med 2005; 201: 1591–602
   PubMed Web of Science ®Google Scholar
• Fehleisen F. Über die Züchtung der Erysipelkokken auf künstlichem Nährboden und die Übertragbarkeit auf den Menschen. Dtsch Med Wochenschau 1882; 8: 553
   Google Scholar
• Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother 2001; 50: 391–6
   PubMed Web of Science ®Google Scholar
• Busch W. Aus der Sitzung der medizinischen Sektion vom 13 November 1867. Berl Klin Wochenschr 1868; 5: 137
   Google Scholar
• Coley W. B. A preliminary note on the treatment of inoperable sarcoma by the toxic product of erysipelas. Postgraduate 1893; 8: 278
   Google Scholar
• Goldszmid R. S., Idoyaga J., Bravo A. I., Steinman R., Mordoh J., Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long‐lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol 2003; 171: 5940–7
   PubMed Web of Science ®Google Scholar
• Rechtsteiner G., Warger T., Osterloh P., Schild H., Radsak M. P. Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J Immunol 2005; 174: 2476–80
   PubMed Web of Science ®Google Scholar
• Warger T., Osterloh P., Rechtsteiner G., Fassbender M., Heib V., Schmid B., et al. Synergistic activation of dendritic cells by combined Toll‐like receptor ligation induces superior CTL responses in vivo. Blood 2006; 108: 544–50
   PubMed Web of Science ®Google Scholar
• Yang Y., Huang C. T., Huang X., Pardoll D. M. Persistent Toll‐like receptor signals are required for reversal of regulatory T cell‐mediated CD8 tolerance. Nat Immunol 2004; 5: 508–15
   PubMed Web of Science ®Google Scholar
• Rouse B. T., Suvas S. Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol 2004; 173: 2211–5
   PubMed Web of Science ®Google Scholar
• Suvas S., Azkur A. K., Kim B. S., Kumaraguru U., Rouse B. T. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004; 172: 4123–32
   PubMed Web of Science ®Google Scholar
• Powrie F., Read S., Mottet C., Uhlig H., Maloy K. Control of immune pathology by regulatory T cells. Novartis Found Symp 2003; 252: 92–8
   PubMedGoogle Scholar
• Mottet C., Uhlig H. H., Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939–43
   PubMed Web of Science ®Google Scholar
• Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M., Sacks D. L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502–7
   PubMed Web of Science ®Google Scholar
• Yurchenko E., Tritt M., Hay V., Shevach E. M., Belkaid Y., Piccirillo C. A. CCR5‐dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 2006; 203: 2451–60
   PubMed Web of Science ®Google Scholar
• Iwasaki A., Medzhitov R. Toll‐like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987–95
   PubMed Web of Science ®Google Scholar
• Pasare C., Medzhitov R. Toll pathway‐dependent blockade of CD4+CD25+ T cell‐mediated suppression by dendritic cells. Science 2003; 299: 1033–6
   PubMed Web of Science ®Google Scholar
• Pasare C., Medzhitov R. Toll‐dependent control mechanisms of CD4 T cell activation. Immunity 2004; 21: 733–41
   PubMed Web of Science ®Google Scholar
• Thornton A. M., Donovan E. E., Piccirillo C. A., Shevach E. M. Cutting edge: IL‐2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004; 172: 6519–23
   PubMed Web of Science ®Google Scholar
• Sutmuller R. P., den Brok M. H., Kramer M., Bennink E. J., Toonen L. W., Kullberg B. J., et al. Toll‐like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116: 485–94
   PubMed Web of Science ®Google Scholar
• Stassen M., Jonuleit H., Muller C., Klein M., Richter C., Bopp T., et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004; 267–74, 173
   Google Scholar
• Zhao D. M., Thornton A. M., Dipaolo R. J., Shevach E. M. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006; 107: 3925–32
   PubMed Web of Science ®Google Scholar
• Woo E. Y., Chu C. S., Goletz T. J., Schlienger K., Yeh H., Coukos G., et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early‐stage non‐small cell lung cancer and late‐stage ovarian cancer. Cancer Res 2001; 61: 4766–72
   PubMed Web of Science ®Google Scholar
• Wolf A. M., Wolf D., Steurer M., Gastl G., Gunsilius E., Grubeck‐Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9: 606–12
   PubMed Web of Science ®Google Scholar
• Antony P. A., Piccirillo C. A., Akpinarli A., Finkelstein S. E., Speiss P. J., Surman D. R., et al. CD8+ T cell immunity against a tumor/self‐antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 2005; 174: 2591–601
   PubMed Web of Science ®Google Scholar
• Gray C. P., Arosio P., Hersey P. Association of increased levels of heavy‐chain ferritin with increased CD4+ CD25+ regulatory T‐cell levels in patients with melanoma. Clin Cancer Res 2003; 9: 2551–9
   PubMed Web of Science ®Google Scholar
• Enk A. H., Jonuleit H., Saloga J., Knop J. Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma. Int J Cancer 1997; 73: 309–16
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A. Shedding light on immunotherapy for cancer. N Engl J Med 2004; 350: 1461–3
   PubMed Web of Science ®Google Scholar
• O'Neill D. W., Adams S., Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004; 104: 2235–46
   PubMed Web of Science ®Google Scholar
• Pasare C., Medzhitov R. Toll‐like receptors: balancing host resistance with immune tolerance. Curr Opin Immunol 2003; 15: 677–82
   PubMed Web of Science ®Google Scholar
• Viglietta V., Baecher‐Allan C., Weiner H. L., Hafler D. A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971–9
   PubMed Web of Science ®Google Scholar
• Cao D., Malmstrom V., Baecher‐Allan C., Hafler D., Klareskog L., Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215–23
   PubMed Web of Science ®Google Scholar
• Lindley S., Dayan C. M., Bishop A., Roep B. O., Peakman M., Tree T. I. Defective suppressor function in CD4(+)CD25(+) T‐cells from patients with type 1 diabetes. Diabetes 2005; 54: 92–9
   PubMed Web of Science ®Google Scholar
• Sugiyama H., Gyulai R., Toichi E., Garaczi E., Shimada S., Stevens S. R., et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174: 164–73
   PubMed Web of Science ®Google Scholar
• Ehrenstein M. R., Evans J. G., Singh A., Moore S., Warnes G., Isenberg D. A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti‐TNFalpha therapy. J Exp Med 2004; 200: 277–85
   PubMed Web of Science ®Google Scholar
• Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D. F., et al. Reversing the defective induction of IL‐10‐secreting regulatory T cells in glucocorticoid‐resistant asthma patients. J Clin Invest 2006; 116: 146–55
   PubMed Web of Science ®Google Scholar
• Karagiannidis C., Akdis M., Holopainen P., Woolley N. J., Hense G., Ruckert B., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425–33
   PubMed Web of Science ®Google Scholar
• Keymeulen B., Vandemeulebroucke E., Ziegler A. G., Mathieu C., Kaufman L., Hale G., et al. Insulin needs after CD3‐antibody therapy in new‐onset type 1 diabetes. N Engl J Med 2005; 352: 2598–608
   PubMed Web of Science ®Google Scholar
• Herold K. C., Gitelman S. E., Masharani U., Hagopian W., Bisikirska B., Donaldson D., et al. A single course of anti‐CD3 monoclonal antibody hOKT3gamma1(Ala‐Ala) results in improvement in C‐peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005; 54: 1763–9
   PubMed Web of Science ®Google Scholar
• Belghith M., Bluestone J. A., Barriot S., Megret J., Bach J. F., Chatenoud L. TGF‐beta‐dependent mechanisms mediate restoration of self‐tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9: 1202–8
   PubMed Web of Science ®Google Scholar
• Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen‐specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567–75
   PubMed Web of Science ®Google Scholar
• Bellinghausen I., Knop J., Saloga J. The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 2001; 126: 97–101
   PubMedGoogle Scholar